Litman Gregory Wealth Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-853
Closed -$27K 46
2016
Q4
$27K Sell
853
-757
-47% -$25.4K 0.02% 39
2016
Q3
$55K Hold
1,610
0.04% 29
2016
Q2
$57K Hold
1,610
0.05% 27
2016
Q1
$57K Buy
+1,610
New +$56.9K 0.05% 31

Other funds holding BME

Litman Gregory Wealth Management's BME Position: Q1 2017 in Review

Litman Gregory Wealth Management sold out of BlackRock Health Sciences Trust (BME) in Q1 2017, closing a stake of 853 shares — an estimated $27K sold.

Litman Gregory Wealth Management first reported a position in BME in Q1 2016 and held it in 4 quarters. The position peaked at $57K in Q2 2016. 27 funds tracked by Wall St. Rank hold BME as of Q1 2017.

  • Litman Gregory Wealth Management reported no remaining BlackRock Health Sciences Trust position as of Q1 2017 after selling out during the quarter.
  • Litman Gregory Wealth Management sold 853 BlackRock Health Sciences Trust shares in Q1 2017, an estimated $27K.
  • Litman Gregory Wealth Management first reported a position in BlackRock Health Sciences Trust in Q1 2016 and held it in 4 quarters.
  • Litman Gregory Wealth Management's BlackRock Health Sciences Trust position peaked at $57K in Q2 2016.
  • 27 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2017.

Based on Litman Gregory Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.